06/06/2025
9:03 AM | FMR LLC (Filed by)
Jade Biosciences, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/05/2025
8:43 AM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Jade Biosciences, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/01/2025
5:31 PM | Fairmount Funds Management LLC (Filed by)
Jade Biosciences, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form SCHEDULE 13D | |
05/01/2025
4:44 PM | Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:51 PM | Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Lavelle Erin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:58 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Kiselak Tomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
5:00 PM | DOBMEIER ERIC (Reporting)
Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:07 PM | CAIN CHRISTOPHER W. (Reporting)
Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:10 PM | Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:15 PM | Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Lavelle Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:16 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for JBIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/01/2025
4:21 PM | Frohlich Tom (Reporting)
Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:22 PM | Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Quick Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:27 PM | Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
King Andrew James (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:30 PM | Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Kocinsky Hetal (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:32 PM | Balta Elizabeth (Reporting)
Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:39 PM | DOBMEIER ERIC (Reporting)
Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:41 PM | CAIN CHRISTOPHER W. (Reporting)
Jade Biosciences, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
3:22 PM | Jade Biosciences, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
3:30 PM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
3:37 PM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
7:07 AM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
3:20 PM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
04/09/2025
6:00 AM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
6:01 AM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
04/07/2025
7:39 AM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2025
7:42 AM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
04/07/2025
7:46 AM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
03/27/2025
6:30 AM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2025
3:54 PM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
03/25/2025
11:15 PM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form EFFECT | |
03/25/2025
3:25 PM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 424B3 | |
03/24/2025
9:45 AM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form S-4/A | |
03/14/2025
4:16 PM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form S-4/A | |
03/03/2025
3:45 PM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
02/24/2025
8:57 AM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form S-4/A | |
01/24/2025
3:17 PM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
01/22/2025
7:45 AM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form S-4/A | |
01/13/2025
4:24 PM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
12/03/2024
5:27 AM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
11/18/2024
4:29 PM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
When This Happens, You Don’t Wait. You Act. (Ad) This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto.
Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave. Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin |
10/31/2024
3:55 PM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:55 PM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:57 PM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:57 PM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
8:27 AM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
8:29 AM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
| Form 425 | |
10/17/2024
3:59 PM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:04 PM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:31 PM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
5:00 PM | Aerovate Therapeutics, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
7:00 AM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
5:00 PM | Aerovate Therapeutics, Inc. (Subject)
Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
06/20/2024
4:56 PM | Aerovate Therapeutics, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:35 AM | Aerovate Therapeutics, Inc. (Filer)
Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
5:00 PM | Aerovate Therapeutics, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:00 PM | Aerovate Therapeutics, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:00 PM | Aerovate Therapeutics, Inc. (Issuer)
Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy JBIO Stock Free JBIO Stock Alerts